Skip to main content
SpringerLink
Log in

Consider the underlying illness when treating acute agitation in paediatric patients

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Sonnier L, Barzman, D. Pharmacologic management of acutely agitated pediatric patients. Pediatr Drugs 2011; 13(1): 1–10

    Article  Google Scholar 

  2. Pappadopulos E, Macintyre II JC, Crismon ML, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY): part II. J Am Acad Child Adolesc Psychiatry 2003 Feb; 42(2): 145–61

    Article  PubMed  Google Scholar 

  3. Currier GW, Medori R. Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergencies. J Psychiatr Pract 2006 Jan; 12(1): 30–40

    Article  PubMed  Google Scholar 

  4. Dulcan M, editor. Dulcan’s textbook of child and adolescent psychiatry. New York: American Psychiatric Publishing, 2009

    Book  Google Scholar 

  5. Sadock BJ, Sadock VA. Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences, clinical psychiatry. 9th ed. Philadelphia (PA): Lippincott, Williams and Wilkins, 2003

    Google Scholar 

  6. Dorfman DH, Kastner B. The use of restraint for pediatric psychiatric patients in emergency departments. Pediatr Emerg Care 2004 Mar; 20(3): 151–6

    Article  PubMed  Google Scholar 

  7. Zimbroff DL. Pharmacological control of acute agitation: focus on intramuscular preparations. CNS Drugs 2008; 22(3): 199–212

    Article  PubMed  CAS  Google Scholar 

  8. Stahl S. Essential psychopharmacology: the prescriber’s guide, revised and updated edition. New York (NY): Cambridge University Press, 2006

  9. Cheng-Shannon J, McGough JJ, Pataki C, et al. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2004 Fall; 14(3): 372–94

    Article  PubMed  Google Scholar 

  10. Antia SX, Sholevar EH, Baron DA. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol 2005 Dec; 15(6): 970–85

    Article  PubMed  Google Scholar 

  11. Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry 2008; 47(1): 9–20

    Article  PubMed  Google Scholar 

  12. Currier GW, Chou JC, Feifel D, et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry 2004 Mar; 65(3): 386–94

    Article  PubMed  CAS  Google Scholar 

  13. Zimbroff DL, Allen MH, Battaglia J, et al. Best clinical practive with ziprasidone IM: update after 2 years of experience. CNS Spectr 2005 Sep; 10(9): 1–15

    PubMed  Google Scholar 

  14. Wilhelm S, Schacht A, Wanger T. Use of antipsychotics and benzo-diazepines in patients with psychiatric emergencies: results of an observational trial. BMC Psychiatry 2008; 8: 61

    Article  PubMed  Google Scholar 

  15. Barzman DH, DelBello MP, Kowatch RA, et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacology 2004; 14(4): 593–600

    Article  Google Scholar 

  16. Citrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 2007 Dec; 68(12): 1876–85

    Article  PubMed  CAS  Google Scholar 

  17. Glassman AH, Bigger Jr JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001 Nov; 158(11): 1774–82

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Consider the underlying illness when treating acute agitation in paediatric patients. Drugs Ther. Perspect 27, 14–17 (2011). https://doi.org/10.2165/11208020-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11208020-000000000-00000

Search

Navigation